Mantle Cell Lymphoma
Author and Disclosure Information [Show]

Carla Casulo, MD
Assistant Professor of Medicine and Oncology, Lymphoma Program, Wilmot Cancer Institute, University of Rochester, Rochester, NY

Question 1 of 5

A 47-year-old man with newly diagnosed mantle cell lymphoma (MCL) presents for evaluation. He has no other past medical history. He works as a mechanic. On exam he has multiple abnormal lymph nodes palpable in the neck, axillae, and groin. He reports that he feels poorly. Laboratory evaluation reveals an elevated white blood cell (WBC) count and elevated lactate dehydrogenase (LDH) level. Computed tomography (CT) scan demonstrates diffuse lymphadenopathy. He is found to have stage III disease involving multiple lymph nodes in the cervical, mediastinal, and inguinal areas. Bone marrow biopsy is negative for involvement. His MCL International Prognostic Index (MIPI) score is high risk. Lymph node biopsy reveals sheets of medium-sized lymphocytes that are clonal, CD20+, CD5+, and CD23–, and cyclin D1 stains strongly.

What is the preferred approach to treatment?

Bendamustine and rituximab for 6 cycles followed by maintenance rituximab

R-CHOP (rituximab with cyclophosphamide, doxorubicin, vincristine, prednisone ) for 6 cycles followed by observation

R-CHOP induction followed by a cytarabine-based conditioning regimen, high-dose chemotherapy, and autologous stem cell transplant


Hospital Physician: Hematology/Oncology. 2017 March;12(2)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology


Autoimmune Hemolytic Anemia
Gastrointestinal Stromal Tumors
Testicular Cancer
Management of Advanced Melanoma
Castration-Resistant Prostate Cancer
Transfusion Reactions (part 2)
Transfusion Reactions (part 1)
Plasma Cell Disorders (part 3)
Plasma Cell Disorders (part 2)
Chronic Myeloid Leukemia
Aplastic Anemia
Small Cell Lung Cancer
Management of Metastatic Gastric Cancer
Transfusion Medicine
Management of Colorectal Cancer in Older Adults
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Acute Myeloid Leukemia
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Aggressive B-Cell Non-Hodgkin Lymphoma
Von Willebrand Disease: Clinical Management
Von Willebrand Disease: Assessment and Diagnostic Testing
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Hairy Cell Leukemia
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Adjuvant Chemotherapy for Colon Cancer
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease